The highly customized nature of cell and gene therapy production means that manufacturing innovations for one therapy may not be easily transferable to others.
Pascale Diesel
Advertisement
Pascale Diesel is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.
Articles by Pascale Diesel
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.
Advertisement
Latest Updated Articles
- The Link Between Manufacturing and Commercialization in Gene and Cell Therapy
Published: March 20th 2019 | Updated:
The Link Between Manufacturing and Commercialization in Gene and Cell TherapiesPublished: May 15th 2019 | Updated:
Advertisement
Advertisement
